Physician profile
Danielle Turner
NPI 1528695723
$568.49
in general payments reported to CMS, 2019-2025
11 companies · $264 in 2025
The $264 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29.63 · 2024: $275 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $108.15 | 2024-2025 | |
| Tris Pharma INC | $96.84 | 2024-2025 | Dyanavel Xr, Onyda Xr |
| Cranial Technologies, INC | $85.19 | 2024-2025 | Doc Band |
| Biomarin Pharmaceutical INC. | $53.05 | 2025 | Voxzogo 1.2mg |
| Corium, LLC | $50.86 | 2024 | Azstarys |
| Pfizer INC. | $47.88 | 2023-2024 | |
| Cumberland Pharmaceuticals, INC. | $43.96 | 2024-2025 | Kristalose |
| Sobi, INC | $27.04 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $21.95 | 2024 | Crysvita |
| Gilead Sciences, INC. | $18.62 | 2025 | |
| Merck Sharp & Dohme LLC | $14.95 | 2024 | Gardasil, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.